Makefield Therapeutics' vision:

To advance the clinical applications of its  proprietary and enabling "Hybrid Nanoparticle Technology Platform" to address large markets with unmet clinical needs. 

The Company's lead development programs are focused on:
 
    1) A topical treatment for erectile dysfunction (ED) in 
        men unresponsive to currently available treatments

    2) A broad spectrum topical antimicrobial for
        the treatment of drug resistant infections 
        of wounds and abscesses.